{"url_path":"/sec/cntb/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1835268/0001835268-26-000020-index.html","accession_number":"0001835268-26-000020","cik":"0001835268","ticker":"CNTB","issuer_name":"Connect Biopharma Holdings Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1835268/0001835268-26-000020-index.html","primary_entity_key":"0001835268","primary_entity_name":"Connect Biopharma Holdings Ltd"},"word_count":60,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nUnregistered Sales of Equity Securities\n\nExcept as disclosed in a Current Report on Form 8-K filed with the SEC on March 30, 2026, there were no other sales of unregistered equity securities during the quarter ended March 31, 2026.\n\nIssuer Purchases of Equity Securities\n\nNone.\n\n24\n\n[TABLE OF CONTENTS](#i46b71458e1224d37a858ff5acc38daea_7)"}